InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include the VaxArray® Portfolio of game-changing multiplexed potency assays for vaccines and the CypherOne System for digital imaging and automated interpretation of hemagglutination assays.
InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux – a worldwide leader in in vitro diagnostics and microbi... (more)
